Although these differences did not reach statistical significance in this small cohort, there is a known link between increasingly aggressive multimodal therapies and lymphedema risk ( 21 – 23 ).
← all excerpts
Use of axillary vascular grafts in prophylactic lymphovenous bypass: technical challenges and lessons learned.
1
—
—